Balyasny Asset Management LLC Adagio Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
N/A
-6,557 Reduced 7.56%
80,230 $265,000
Q4 2023

Feb 14, 2024
BUY
N/A
86,787 New
86,787 $287,000
Q2 2023

Aug 14, 2023
BUY
N/A
13,056 New
13,056 $43,000
Q1 2022

May 16, 2022
SELL
$3.81 - $10.77 $998,962 - $2.82 Million
-262,195 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$6.35 - $47.04 $1.66 Million - $12.3 Million
262,195 New
262,195 $1.9 Million

Others Institutions Holding ADGI

# of Institutions
78
Shares Held
63.9M
Call Options Held
2.3K
Put Options Held
2.1K
View Full List

About Adagio Therapeutics, Inc.

ADGI Quotes by TradingView
  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email